Early adopters - mpMRI before biopsy usage

Prostate Cancer UK undertook a Freedom of Information Act (FOI) request of all Trusts, Health Boards and Health and Social Care Trusts in 2016 with the aim of achieving a state of the nation overview of the use of mpMRI before biopsy.

With a 100% completion rate, we gained an in-depth understanding of the current status of mpMRI before prostate biopsy across the UK. We have used the data to make the case to National Commissioners for implementation support. It has also guided our funding and development of resources that respond to some of the challenges and barriers to implementation that centres told us they faced.

This second round of questions is our means of understanding what progress has been and to identify where we can target our resources and National Commissioners’ support to have maximum impact. Your help with this, is really appreciated.

If you have any questions regarding this FOI request please contact Haddi Browne, Impact and Quality Officer on 020 3310 7214 or on email: haddi.browne@prostatecanceruk.org

Question Title

* 1. Please tell us which Trust, Health Board or Health and Social Care Trust  you are responding on behalf of?

Question Title

* 2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?

Question Title

* 3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?

Question Title

* 4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?

Question Title

* 5. What mpMRI scores and/or other clinical factors are used to rule men out of
biopsy?

Question Title

* 6. Do you intend to use mpMRI to rule men out of biopsy in the future?

Question Title

* 7. How many men annually are referred

a)      On suspicion of prostate cancer?

b)      Eligible for mpMRI?

c)       Scanned?

d)      Biopsied?

Please provide corresponding numbers in the comment box below

Question Title

* 8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.

Question Title

* 9. Do you carry out targeted biopsies in men with mpMRI lesions in
addition to systematic biopsies?

Question Title

* 10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?

Question Title

* 11. Please indicate the number of uroradiologists undertaking prostate MRI

Question Title

* 12. How many scanners do you have available for mpMRI before biopsy?

Question Title

* 13. What percentage of scanner time is dedicated to mpMRI before biopsy?

T